| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |